Suchergebnisse - "Li, Yanying"

PubPharm (9)

1

Real-world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations : A multi-center study

enthalten in: Cancer science | 2023

von Qin, Y. | Long, Y. | Tang, Y. | +15

2

The impact of baseline brain metastases on clinical benefits and progression patterns after first-line crizotinib in anaplastic lymphoma kinase-rearranged non-small cell lung cancer

enthalten in: Medicine | 2021

von Chen, Y. | Cai, C. | Li, Y.

3

Distribution and therapeutic outcomes of intergenic sequence-ALK fusion and coexisting ALK fusions in lung adenocarcinoma patients

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2021

von Cai, C. | Tang, Y. | Li, Y. | +11

4

Applicability of the adjusted graded prognostic assessment for lung cancer with brain metastases using molecular markers (Lung-molGPA) in a Chinese cohort : A retrospective study of multiple institutions

enthalten in: Cancer medicine | 2020

von Zhang, T. | Zhang, Y. | Zhou, L. | +21

5

Durable complete response after afatinib and crizotinib in an advanced non-small cell lung cancer patient with EGFR L861Q mutation and acquired MET amplification : a case report

enthalten in: Annals of palliative medicine | 2020

von Long, Y. | Zhang, K. | Li, Y. | +3

6

Novel NLRC4-ALK and EML4-ALK double fusion mutations in a lung adenocarcinoma patient : A case report

enthalten in: Thoracic cancer | 2020

von Wu, X. | Wang, W. | Zou, B. | +7

7

Progression of malignant pleural effusion during the early stage of gefitinib treatment in advanced EGFR-mutant lung adenocarcinoma involving complex driver gene mutations

enthalten in: Signal transduction and targeted therapy | 2020

von Liu, N. | Yu, M. | Yin, T. | +7

8

Progression of Central Nervous System Metastases in Advanced Nonsmall Cell Lung Cancer Patients Effectively Treated with First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor

enthalten in: Cancer biotherapy & radiopharmaceuticals | 2018

von Yu, M. | Zhao, Q. | Li, Y. | +12

9

Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for lung squamous carcinomas harboring EGFR mutation : A multicenter study and pooled analysis of published reports

enthalten in: Oncotarget | 2017

von Liu, Y. | Zhang, Y. | Zhang, L. | +15

1
[1]